-
Mashup Score: 6
The results show dose-dependent LDL-lowering and, in contrast to what was seen previously with VERVE-101, no safety issues.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Weekend Warriors Also See Mortality Benefits With Exercise - 6 day(s) ago
The study is the latest showing that it doesn’t matter how exercise gets done in a week, as long as it gets done.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet-
New analysis concludes that "weekend warriors," who cram all their physical activity for the week into just a few days, see low risks of mortality comparable to those who spread activity out throughout the week. Read more here: https://t.co/YEM5P0Qhss https://t.co/lVk2W83R7n
-
-
Mashup Score: 1Cardiologists Plot Next Moves After New Board Rejected - 7 day(s) ago
The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Cardiologists Plot Next Moves After New Board Rejected https://t.co/rwrqTnJ4XR https://t.co/mUGehtrITL
-
-
Mashup Score: 0COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year - 7 day(s) ago
There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year https://t.co/3EWYSMLwi8 https://t.co/WJjpXSjC2Z
-
-
Mashup Score: 21
The follow-up data bolster the gains in quality of life seen at 1 year and provide evidence of clinical benefit with TEER.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Tricuspid TEER treatment found to reduce hospitalizations for heart failure, according to the TRILUMINATE data presented at #ACC25. For more details and comments from Saibal Kar, Laura Davidson, and @GilbertTangMD, read here: https://t.co/cNc0Ef3okR https://t.co/2d94evlMAO
-
-
Mashup Score: 1Weekend Warriors Also See Mortality Benefits With Exercise - 7 day(s) ago
The study is the latest showing that it doesn’t matter how exercise gets done in a week, as long as it gets done.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Weekend Warriors Also See Mortality Benefits With Exercise https://t.co/xaxa9PHJxc https://t.co/CsQvQcCUBP
-
-
Mashup Score: 3Formalizing Interventional Heart Failure Training? - 8 day(s) ago
Marat Fudim and Rishi Trivedi discuss the challenges ahead as the field aims to become more attractive to trainees.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Should there be a formalized interventional heart failure training? @FudimMarat and @RishiKTrived discuss the possibilities and the challenges with @TCTMD_Yael in this Fellows Forum video: https://t.co/5TFEVG3XXo To get involved with the Fellows Forum: https://t.co/FDo75y4iHr https://t.co/tMjpFGHL2f
-
-
Mashup Score: 1Aditya Mehta, MBBS - 8 day(s) ago
The dynamic field of advanced heart failure, and helping these patients live comfortably, has inspired this fellow.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Aditya Mehta, MBBS https://t.co/i1QtEBvhqw
-
-
Mashup Score: 1
With phase III trials ongoing, durable lepodisiran effects with no serious events are considered reassuring.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) https://t.co/khc3MyFEqb https://t.co/vHurwv1Ppk
-
-
Mashup Score: 6FDA Drops REMS Requirement for Antihypertensive Aprocitentan - 8 day(s) ago
The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
US FDA (@US_FDA) removes the REMS requirement from aprocitentan (Tryvio), as announced by @IdorsiaUS. Read the full update: https://t.co/Q3lyW1GU0z https://t.co/IUyyHVRH9e
-
Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy https://t.co/YdDsPfWkJl https://t.co/evVcSvi1yD